Dr Tyler Goettl, MD - Medicare General Surgery in Willmar, MN

Dr Tyler Goettl, MD is a medicare enrolled "Surgery" physician in Willmar, Minnesota. He went to University Of Minnesota Medical School and graduated in 2015 and has 9 years of diverse experience with area of expertise as General Surgery. He is a member of the group practice Centracare Clinic Southwest Llc and his current practice location is 101 Willmar Ave Sw, Willmar, Minnesota. You can reach out to his office (for appointments etc.) via phone at (320) 231-5000.

Dr Tyler Goettl is licensed to practice in Minnesota (license number 63799) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1205213881.

Contact Information

Dr Tyler Goettl, MD
101 Willmar Ave Sw,
Willmar, MN 56201-3556
(320) 231-5000
Not Available



Physician's Profile

Full NameDr Tyler Goettl
GenderMale
SpecialityGeneral Surgery
Experience9 Years
Location101 Willmar Ave Sw, Willmar, Minnesota
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Tyler Goettl attended and graduated from University Of Minnesota Medical School in 2015
  NPI Data:
  • NPI Number: 1205213881
  • Provider Enumeration Date: 05/02/2015
  • Last Update Date: 07/06/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 3971809484
  • Enrollment ID: I20201005000621

Medical Identifiers

Medical identifiers for Dr Tyler Goettl such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1205213881NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208600000XSurgery 63799 (Minnesota)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Carris Health LlcWillmar, MNHospital
Carris Health - Redwood, LlcRedwood falls, MNHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Centracare Clinic Southwest Llc8426457946141

News Archive

FDA-regulated product information for consumers and health care professionals

The U.S. Food and Drug Administration today issued its Strategic Plan for Risk Communication, which outlines the agency's efforts to disseminate more meaningful public health information.

Lancet series examines health challenges in India

"Indians are growing richer, but they are also adopting unhealthy lifestyles that could take years off their lives and threaten economic growth," according to an article published in Lancet Tuesday, Agence France-Presse reports (1/11). The article is one of seven published in the Lancet as part of a series that also includes a set of commentary pieces on health issues facing the country (1/11).

Researchers examine ischemic complications in patients who receive flow-diverting stents

The use of flow-diverting stents to treat intracranial aneurysms appears safe and highly successful. Recently, however, there have been reports of ischemic complications occurring in brain territories supplied by the parent artery in which the stent is placed and in brain regions fed by small arterial branches whose ostia are covered by the stent.

Anti-AIDS gel shows promise

Dr. Ian McGowan, a professor of medicine at the University of Pittsburgh who is leading a second-phase study of the gel said, "These are early results, but [they] help set the stage for current and future trials of rectal microbicides and the development of a rectal-specific formulation of tenofovir gel." Researchers have focused on the use of microbicides such as tenofovir, as a preventive treatment to be used in vaginal sex. However, scientists think unprotected anal sex is much more risky.

Profectus' GENEVAX IL-12 pDNA adjuvant improves vaccine-induced response rate in Phase I HIV study

Profectus Biosciences, Inc., a leader in the development of therapeutic and preventive vaccines against infectious diseases and cancers, announced today that its GENEVAX™ IL-12 pDNA adjuvant has significantly improved the vaccine-induced response rate in a Phase I clinical study of an experimental DNA vaccine for the prevention of HIV infection.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Tyler Goettl allows following entities to bill medicare on his behalf.
Entity NameSwift County-benson Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1174529002
PECOS PAC ID: 8729069281
Enrollment ID: O20040528001145

News Archive

FDA-regulated product information for consumers and health care professionals

The U.S. Food and Drug Administration today issued its Strategic Plan for Risk Communication, which outlines the agency's efforts to disseminate more meaningful public health information.

Lancet series examines health challenges in India

"Indians are growing richer, but they are also adopting unhealthy lifestyles that could take years off their lives and threaten economic growth," according to an article published in Lancet Tuesday, Agence France-Presse reports (1/11). The article is one of seven published in the Lancet as part of a series that also includes a set of commentary pieces on health issues facing the country (1/11).

Researchers examine ischemic complications in patients who receive flow-diverting stents

The use of flow-diverting stents to treat intracranial aneurysms appears safe and highly successful. Recently, however, there have been reports of ischemic complications occurring in brain territories supplied by the parent artery in which the stent is placed and in brain regions fed by small arterial branches whose ostia are covered by the stent.

Anti-AIDS gel shows promise

Dr. Ian McGowan, a professor of medicine at the University of Pittsburgh who is leading a second-phase study of the gel said, "These are early results, but [they] help set the stage for current and future trials of rectal microbicides and the development of a rectal-specific formulation of tenofovir gel." Researchers have focused on the use of microbicides such as tenofovir, as a preventive treatment to be used in vaginal sex. However, scientists think unprotected anal sex is much more risky.

Profectus' GENEVAX IL-12 pDNA adjuvant improves vaccine-induced response rate in Phase I HIV study

Profectus Biosciences, Inc., a leader in the development of therapeutic and preventive vaccines against infectious diseases and cancers, announced today that its GENEVAX™ IL-12 pDNA adjuvant has significantly improved the vaccine-induced response rate in a Phase I clinical study of an experimental DNA vaccine for the prevention of HIV infection.

Read more Medical News

› Verified 4 days ago

Entity NameCarris Health - Redwood Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1265914048
PECOS PAC ID: 7911259619
Enrollment ID: O20181129001082

News Archive

FDA-regulated product information for consumers and health care professionals

The U.S. Food and Drug Administration today issued its Strategic Plan for Risk Communication, which outlines the agency's efforts to disseminate more meaningful public health information.

Lancet series examines health challenges in India

"Indians are growing richer, but they are also adopting unhealthy lifestyles that could take years off their lives and threaten economic growth," according to an article published in Lancet Tuesday, Agence France-Presse reports (1/11). The article is one of seven published in the Lancet as part of a series that also includes a set of commentary pieces on health issues facing the country (1/11).

Researchers examine ischemic complications in patients who receive flow-diverting stents

The use of flow-diverting stents to treat intracranial aneurysms appears safe and highly successful. Recently, however, there have been reports of ischemic complications occurring in brain territories supplied by the parent artery in which the stent is placed and in brain regions fed by small arterial branches whose ostia are covered by the stent.

Anti-AIDS gel shows promise

Dr. Ian McGowan, a professor of medicine at the University of Pittsburgh who is leading a second-phase study of the gel said, "These are early results, but [they] help set the stage for current and future trials of rectal microbicides and the development of a rectal-specific formulation of tenofovir gel." Researchers have focused on the use of microbicides such as tenofovir, as a preventive treatment to be used in vaginal sex. However, scientists think unprotected anal sex is much more risky.

Profectus' GENEVAX IL-12 pDNA adjuvant improves vaccine-induced response rate in Phase I HIV study

Profectus Biosciences, Inc., a leader in the development of therapeutic and preventive vaccines against infectious diseases and cancers, announced today that its GENEVAX™ IL-12 pDNA adjuvant has significantly improved the vaccine-induced response rate in a Phase I clinical study of an experimental DNA vaccine for the prevention of HIV infection.

Read more Medical News

› Verified 4 days ago

Entity NameCarris Health Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1598236408
PECOS PAC ID: 7012274228
Enrollment ID: O20190503001162

News Archive

FDA-regulated product information for consumers and health care professionals

The U.S. Food and Drug Administration today issued its Strategic Plan for Risk Communication, which outlines the agency's efforts to disseminate more meaningful public health information.

Lancet series examines health challenges in India

"Indians are growing richer, but they are also adopting unhealthy lifestyles that could take years off their lives and threaten economic growth," according to an article published in Lancet Tuesday, Agence France-Presse reports (1/11). The article is one of seven published in the Lancet as part of a series that also includes a set of commentary pieces on health issues facing the country (1/11).

Researchers examine ischemic complications in patients who receive flow-diverting stents

The use of flow-diverting stents to treat intracranial aneurysms appears safe and highly successful. Recently, however, there have been reports of ischemic complications occurring in brain territories supplied by the parent artery in which the stent is placed and in brain regions fed by small arterial branches whose ostia are covered by the stent.

Anti-AIDS gel shows promise

Dr. Ian McGowan, a professor of medicine at the University of Pittsburgh who is leading a second-phase study of the gel said, "These are early results, but [they] help set the stage for current and future trials of rectal microbicides and the development of a rectal-specific formulation of tenofovir gel." Researchers have focused on the use of microbicides such as tenofovir, as a preventive treatment to be used in vaginal sex. However, scientists think unprotected anal sex is much more risky.

Profectus' GENEVAX IL-12 pDNA adjuvant improves vaccine-induced response rate in Phase I HIV study

Profectus Biosciences, Inc., a leader in the development of therapeutic and preventive vaccines against infectious diseases and cancers, announced today that its GENEVAX™ IL-12 pDNA adjuvant has significantly improved the vaccine-induced response rate in a Phase I clinical study of an experimental DNA vaccine for the prevention of HIV infection.

Read more Medical News

› Verified 4 days ago

Entity NameCentracare Clinic Southwest Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1174106264
PECOS PAC ID: 8426457946
Enrollment ID: O20210602002802

News Archive

FDA-regulated product information for consumers and health care professionals

The U.S. Food and Drug Administration today issued its Strategic Plan for Risk Communication, which outlines the agency's efforts to disseminate more meaningful public health information.

Lancet series examines health challenges in India

"Indians are growing richer, but they are also adopting unhealthy lifestyles that could take years off their lives and threaten economic growth," according to an article published in Lancet Tuesday, Agence France-Presse reports (1/11). The article is one of seven published in the Lancet as part of a series that also includes a set of commentary pieces on health issues facing the country (1/11).

Researchers examine ischemic complications in patients who receive flow-diverting stents

The use of flow-diverting stents to treat intracranial aneurysms appears safe and highly successful. Recently, however, there have been reports of ischemic complications occurring in brain territories supplied by the parent artery in which the stent is placed and in brain regions fed by small arterial branches whose ostia are covered by the stent.

Anti-AIDS gel shows promise

Dr. Ian McGowan, a professor of medicine at the University of Pittsburgh who is leading a second-phase study of the gel said, "These are early results, but [they] help set the stage for current and future trials of rectal microbicides and the development of a rectal-specific formulation of tenofovir gel." Researchers have focused on the use of microbicides such as tenofovir, as a preventive treatment to be used in vaginal sex. However, scientists think unprotected anal sex is much more risky.

Profectus' GENEVAX IL-12 pDNA adjuvant improves vaccine-induced response rate in Phase I HIV study

Profectus Biosciences, Inc., a leader in the development of therapeutic and preventive vaccines against infectious diseases and cancers, announced today that its GENEVAX™ IL-12 pDNA adjuvant has significantly improved the vaccine-induced response rate in a Phase I clinical study of an experimental DNA vaccine for the prevention of HIV infection.

Read more Medical News

› Verified 4 days ago

Entity NameCentracare Health - Benson Llc
Entity TypePart A Provider - Critical Access Hospital
Entity IdentifiersNPI Number: 1326757154
PECOS PAC ID: 1850761685
Enrollment ID: O20230203001165

News Archive

FDA-regulated product information for consumers and health care professionals

The U.S. Food and Drug Administration today issued its Strategic Plan for Risk Communication, which outlines the agency's efforts to disseminate more meaningful public health information.

Lancet series examines health challenges in India

"Indians are growing richer, but they are also adopting unhealthy lifestyles that could take years off their lives and threaten economic growth," according to an article published in Lancet Tuesday, Agence France-Presse reports (1/11). The article is one of seven published in the Lancet as part of a series that also includes a set of commentary pieces on health issues facing the country (1/11).

Researchers examine ischemic complications in patients who receive flow-diverting stents

The use of flow-diverting stents to treat intracranial aneurysms appears safe and highly successful. Recently, however, there have been reports of ischemic complications occurring in brain territories supplied by the parent artery in which the stent is placed and in brain regions fed by small arterial branches whose ostia are covered by the stent.

Anti-AIDS gel shows promise

Dr. Ian McGowan, a professor of medicine at the University of Pittsburgh who is leading a second-phase study of the gel said, "These are early results, but [they] help set the stage for current and future trials of rectal microbicides and the development of a rectal-specific formulation of tenofovir gel." Researchers have focused on the use of microbicides such as tenofovir, as a preventive treatment to be used in vaginal sex. However, scientists think unprotected anal sex is much more risky.

Profectus' GENEVAX IL-12 pDNA adjuvant improves vaccine-induced response rate in Phase I HIV study

Profectus Biosciences, Inc., a leader in the development of therapeutic and preventive vaccines against infectious diseases and cancers, announced today that its GENEVAX™ IL-12 pDNA adjuvant has significantly improved the vaccine-induced response rate in a Phase I clinical study of an experimental DNA vaccine for the prevention of HIV infection.

Read more Medical News

› Verified 4 days ago

Entity NameCentracare Health - Benson Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1326757154
PECOS PAC ID: 1850761685
Enrollment ID: O20230411000460

News Archive

FDA-regulated product information for consumers and health care professionals

The U.S. Food and Drug Administration today issued its Strategic Plan for Risk Communication, which outlines the agency's efforts to disseminate more meaningful public health information.

Lancet series examines health challenges in India

"Indians are growing richer, but they are also adopting unhealthy lifestyles that could take years off their lives and threaten economic growth," according to an article published in Lancet Tuesday, Agence France-Presse reports (1/11). The article is one of seven published in the Lancet as part of a series that also includes a set of commentary pieces on health issues facing the country (1/11).

Researchers examine ischemic complications in patients who receive flow-diverting stents

The use of flow-diverting stents to treat intracranial aneurysms appears safe and highly successful. Recently, however, there have been reports of ischemic complications occurring in brain territories supplied by the parent artery in which the stent is placed and in brain regions fed by small arterial branches whose ostia are covered by the stent.

Anti-AIDS gel shows promise

Dr. Ian McGowan, a professor of medicine at the University of Pittsburgh who is leading a second-phase study of the gel said, "These are early results, but [they] help set the stage for current and future trials of rectal microbicides and the development of a rectal-specific formulation of tenofovir gel." Researchers have focused on the use of microbicides such as tenofovir, as a preventive treatment to be used in vaginal sex. However, scientists think unprotected anal sex is much more risky.

Profectus' GENEVAX IL-12 pDNA adjuvant improves vaccine-induced response rate in Phase I HIV study

Profectus Biosciences, Inc., a leader in the development of therapeutic and preventive vaccines against infectious diseases and cancers, announced today that its GENEVAX™ IL-12 pDNA adjuvant has significantly improved the vaccine-induced response rate in a Phase I clinical study of an experimental DNA vaccine for the prevention of HIV infection.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Tyler Goettl is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Tyler Goettl, MD
3955 8th St Ne,
Willmar, MN 56201-9238

Ph: () -
Dr Tyler Goettl, MD
101 Willmar Ave Sw,
Willmar, MN 56201-3556

Ph: (320) 231-5000

News Archive

FDA-regulated product information for consumers and health care professionals

The U.S. Food and Drug Administration today issued its Strategic Plan for Risk Communication, which outlines the agency's efforts to disseminate more meaningful public health information.

Lancet series examines health challenges in India

"Indians are growing richer, but they are also adopting unhealthy lifestyles that could take years off their lives and threaten economic growth," according to an article published in Lancet Tuesday, Agence France-Presse reports (1/11). The article is one of seven published in the Lancet as part of a series that also includes a set of commentary pieces on health issues facing the country (1/11).

Researchers examine ischemic complications in patients who receive flow-diverting stents

The use of flow-diverting stents to treat intracranial aneurysms appears safe and highly successful. Recently, however, there have been reports of ischemic complications occurring in brain territories supplied by the parent artery in which the stent is placed and in brain regions fed by small arterial branches whose ostia are covered by the stent.

Anti-AIDS gel shows promise

Dr. Ian McGowan, a professor of medicine at the University of Pittsburgh who is leading a second-phase study of the gel said, "These are early results, but [they] help set the stage for current and future trials of rectal microbicides and the development of a rectal-specific formulation of tenofovir gel." Researchers have focused on the use of microbicides such as tenofovir, as a preventive treatment to be used in vaginal sex. However, scientists think unprotected anal sex is much more risky.

Profectus' GENEVAX IL-12 pDNA adjuvant improves vaccine-induced response rate in Phase I HIV study

Profectus Biosciences, Inc., a leader in the development of therapeutic and preventive vaccines against infectious diseases and cancers, announced today that its GENEVAX™ IL-12 pDNA adjuvant has significantly improved the vaccine-induced response rate in a Phase I clinical study of an experimental DNA vaccine for the prevention of HIV infection.

Read more News

› Verified 4 days ago


Surgery Doctors in Willmar, MN

Dr. Robert A Kruger, MD
Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201
Phone: 320-231-5000    Fax: 320-231-5067
Dr. Thomas H Lange, MD
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201
Phone: 320-231-5000    Fax: 320-231-5067
Dr. Katherine Faith Reigstad, M.D.
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 101 Willmar Ave Sw, Acmc-willmar, Willmar, MN 56201
Phone: 320-231-5010    Fax: 320-231-5067
Dr. Steven R Bell, MD
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201
Phone: 320-231-5000    Fax: 320-231-5067
Dr. Gordon J Bos, MD
Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201
Phone: 320-231-5000    Fax: 320-231-5067
Dr. Steven L Kidd, MD
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201
Phone: 320-231-5000    Fax: 320-231-5067

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.